Table 1.
Baseline characteristics of CHB and CHC patients.
| Variables Median (IQR) or n (%) | CHB (n = 992) | CHC (n = 1,284) |
|---|---|---|
| Age: years | 45 (19) | 54 (16) |
| Sex | ||
| Female | 252 (25.4) | 663 (51.6) |
| Male | 740 (74.6) | 621 (48.4) |
| Liver stage by biopsy | ||
| F0: no fibrosis | 8 (0.8) | 2 (0.2) |
| F1: portal fibrosis without septa | 280 (28.2) | 368 (28.7) |
| F2: portal fibrosis with few septa | 321 (32.4) | 493 (38.4) |
| F3: numerous septa without cirrhosis | 134 (13.5) | 213 (16.6) |
| F4: cirrhosis | 249 (25.1) | 208 (16.2) |
| Laboratory parameters | ||
| AST: IU/L | 50 (52) | 57 (60) |
| ALT: IU/L | 66 (94) | 77 (90) |
| Total bilirubin: mg/dL | 1.02 (0.53) | 0.96 (0.44) |
| PT: INR | 1.1 (0.1) | 1.1 (0.1) |
| Platelet: ×103/μL | 174 (78.5) | 163 (81.5) |
| Creatinine: mg/dL | 0.88 (0.3) | 0.79 (0.27) |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; CHB, chronic hepatitis B; CHC, chronic hepatitis C; INR, international normalised ratio; PT, prothrombin time.